Medicated Multiple-component Polymeric Nanocomposites Fabricated Using Electrospraying
Source abstract
Abstract
Drug-loaded hydrophilic polymeric composite (HPC) is one of the most promising biomaterials for resolving the long-standing challenge of the development of oral solid formulations for insoluble drugs. With polyvinylpyrrolidone K10 (PVP) as polymeric carrier and sodium dodecyl sulfonate (SDS) as a surface active agent, a new type of HPC was fabricated for enhancing the dissolution of quercetin using an electrospraying process. A solvent mixture consisting of acetic acid, acetone and ethanol were exploited to prepare the co-dissolving solution of quercetin, PVP, and SDS for creating HPC. Both the sprayed nanoparticles and casting film fabricated using a thermal solvent evaporation process were amorphous composites, as demonstrated by the XRD results. ATR-FTIR spectra verified that the drug and the pharmaceutical carriers had good compatibility. In vitro dissolution experiments showed that the sprayed HPC could provide an over ten-fold faster dissolution rate than the casting film. Electrospraying is a facile method for developing new kinds of HPCs for insoluble drugs.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Electrohydrodynamics and Fluid Dynamics · Electrospun Nanofibers in Biomedical Applications · Microfluidic and Capillary Electrophoresis Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Mechanical Engineering, Guang-Xi Technological College of Machinery & Electricity, Nan-Ning 5300037, China
School of Material Science & Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China
References (17)
Show source-provided references
1. 10.1016/j.addr.2015.12.01010.1016/j.addr.2015.12.010 ↗
2. 10.2147/IJN.S2746810.2147/IJN.S27468 ↗
3. 10.1016/j.addr.2016.01.00210.1016/j.addr.2016.01.002 ↗
4. 10.1016/j.ejpb.2013.09.00710.1016/j.ejpb.2013.09.007 ↗
5. 10.1248/cpb.9.86610.1248/cpb.9.866 ↗
6. 10.1016/j.colsurfb.2012.10.01610.1016/j.colsurfb.2012.10.016 ↗
7. 10.1002/pc.2240210.1002/pc.22402 ↗
8. 10.1002/jps.2390410.1002/jps.23904 ↗
9. 10.1016/j.ijpharm.2010.08.01010.1016/j.ijpharm.2010.08.010 ↗
10. 10.1002/jps.2337410.1002/jps.23374 ↗
11. 10.1021/acsami.5b0600710.1021/acsami.5b06007 ↗
12. 10.1016/j.actbio.2016.02.02910.1016/j.actbio.2016.02.029 ↗
13. 10.1016/j.ijpharm.2015.12.02910.1016/j.ijpharm.2015.12.029 ↗
14. 10.1007/s11095-014-1504-210.1007/s11095-014-1504-2 ↗
15. 10.1186/1556-276X-9-25810.1186/1556-276X-9-258 ↗
16. 10.1006/jcis.1998.567610.1006/jcis.1998.5676 ↗
17. 10.1016/j.jconrel.2015.06.00410.1016/j.jconrel.2015.06.004 ↗